FDA Investigator George J Flynn

George J Flynn has inspections in 16 countries as of 29 Sep 2023. George J Flynn has collaborated with a combinined 5907 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
158
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada, China, Czechia, Taiwan, Norway, Slovenia, Japan, Korea (Republic of), Singapore, Germany, Ireland, Slovakia, United Kingdom of Great Britain and Northern Ireland, Finland
Co-Investigator(s):
Abby Lmozeke Baker, Ademola O Daramola, Alan P Kurtzberg, Alice S Tsao, Amanda K Willey, Andrew Saunders, Ann B Borromeo, Ann L Demarco, Anna M Brannen, Anthony Abel, Anthony C Warchut, Arindam Dasgupta, PhD, Arsen Karapetyan, Ashar P Parikh, Azza Talaat, Barbara Jwilimczyk Macri, Bijoy Panicker, Bo Chi, PhD, Bonita S Chester, Bonnie E Conley, Bonnie E Pierson, Brandon C Heitmeier, Brandon C Hernandez, Brendon C Heitmeier, Brian D Nicholson, Brian S Lynch, Brittny C Cargo, Brittny M Mitchell, Bryan A Galvez, Burnell M Henry, C Tyfrans Francis, Carl A Huffman, III, Carla J Lundi, Carolyn E Barney, Carter, CDR Ileana Barreto Pettit, Charanjeet Jassal, Charisse K Green, Charles I Ann, Charles M Edwards, Chauncey A Stephens, Cherie T Parker, Cheryl A Clausen, Cheryl G Scott, Cheryl L Watson, Chris A Sack, Christina A Miller, Christopher J Adams, Christopher T Middendorf, Claire M Minden, Clifton C Francis, Clinton J Lott, Cody D Rickman, Colleen H O'malley, Colleen O'malley, Combs, Cynthia Bolte, Cynthia L Bolte, Cynthia L Medlin, Cynthia R Gibson, Daniel L Aisen, Danielle M Maddox, David P Vanhouten, David R Heiar, Dell S Moller, Demario L Walls, Dennis Cantellops Paite, Dennis P Cantellops, Denti Back, Diane P Goyette, Dina K West, Dinesh Kumar, Don H Bark, PhD, Donald C Obenhuber, PhD, Donna D Gallien, MPH, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Gang Wang, PhD, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Dr. S Nar Ali, PhD, Dyvette Arline, Edward D Mcdonald, Edward H Maticka, Ellen P Madigan, Emily E Smith, Eric L Dong, BS, Eric M Mueller, PharmD, Erin D Mccaffery, Farhana Khan, Felix Maldonado, Francis A Guidry, Frank Wackes, Gam S Zamil, Gary Coody, Geok Yan N Loo, Gerald B Seaborn, Jr, Geraldine D Sanders, Geraldine Sanders, Geroge J Flynn, Goran Periz, PhD, Grace E Mcnally, Grace E Mcnelly, Harshal J Desai, Helen B Ricalde, Helen Verdel, Iris C Macinnes, Ivis Lnegron Torres, Ivy E Sweeney, Jacek Cieslak, PhD, James C Maclaughlin, James L Dunnie, Jr, James R Birkenstamm, James W Blakely, Jamie P Webb, Janet L Bowen, Jared P Stevens, Jason D Abel, Javelle P Spann, Javier O Vega, Jawaid Hamid, Jeffrey P Raimondi, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer L Sheehan, Jennifer Lalama, Jessica L Pressley, John A Podsadowski, John E Russell, Jonathan G Matrisciano, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose M Cayuela, Jose Martinez, Jr, Jose R Hernandez, Jose R Lopez, Joshua P Wireman, Josiah D Davis, Juanita P Versace, Julianne C Mccullough, Juna P Page, June P Page, Justin A Boyd, Karen E D'orazio, Karen Gale Sego, Katherine E Jacobitz, Katherine Szestypalow, Kathy Szestypalau, Kelly D Moore, Kenneth H Williams, Kenneth R Merritt, Kenneth V Miller, Kerry Ann Latham, Kevin A Gonzalez, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Kimberly A Dutzek, Kimberly L Mcmillan, Kip J Hanks, Krista W Whitten, Lacey J Chessor, Lareese K Thomas, Laressa R Gray, Larry K Austin, Latorie S Jones, Laura L Staples, Laurie B Frazier, Lesley K Satterwhite, Libia M Lugo, Linda Agregory Duty, Linda L Ng, Linda Thai, Lindsay H Bertling, Lindsey M Schwierjohann, Liqun Zhao, Lisa M Bellows, Lori S Lawless, Lucas B Leake, Lucila B Nwatu, Luella J Rossi, Luis A Dasta, Luis M Burgos Medero, Marcellinus D Dordunoo, Maressa L Mills, Margaret E Slimbach, Margaret L Bolte, Margarita Santiago, Maria A Reed, Maria C Shih, Marie A Fadden, Marie F Morin, Mark E Parmon, Markeesa M Scales, Martrice A Packer, Marvin D Jones, Mary A Millner, Mary T Carden, Matt D Suedkamp, Matthew B Casale, Matthew G Ellison, Matthew R Mcnew, Maxwell Van Tassell, PhD, Melanie L Drayton, Melinda L Rice, Melissa J Garcia, Melkamu Getie Kebtie, PhD, Meocha V Whaley, Michael A Charles, Michael R Goga, Michael Shanks, MS, Michele Gottshall, Michele L Obert, Michele Perry Williams, Miguel A Martinez, Mra Davism, Mra Mcculloughj, Nadeem I Chaudhry, Nancy M Espinal, Nasir Ali, PhD, Natasha N Mccants, Nebil A Oumer, Nicholas A Violand, Nicole E Knowlton, Noreen Muniz, Pamela M Thomas, Paraluman S Leonin, Parul M Patel, Patricia A Brown, Patricia H Dlugosz, Patricia S Smith, Patrick C Dooley, Patrick C Klotzbuecher, Patrick D Stone, MS, Patrick L Wisor, Patty P Kaewussdangkul, Paul L Bellamy, Paul Mouris, Peggy A Stogner, Peter C Chow, Peter E Baker, Prabhu P Raju, Qin Xu, Raihan A Chowdhury, Ramon A Hernandez, Raymond D Kent, Reba A Gates, Regan T Harp, Richard E Needham, Richard L Rutherford, Richard Needman, Richmond K Yip, Rita K Kabaso, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Martin, Robert L Lewis, Jr, Robert M Tillman, Rory K Geyer, Saied A Asbagh, Sam Pepe, Samantha J Bradley, Samantha J Pinizzotto, D V M, Samina S Khan, Samuel T Walker, Sanders, Sandra A Hughes, Sandy L Atkins, Santos E Camara, Satheesh Thomas, Saundrea A Munroe, Scott T Ballard, Sean R Marcsisin, Sha'tina R Alridge, Sharon K Thoma, PharmD, Shelby N Marler, Shelton L Stribling, Shondra N Gipson, Shrikant N Pagay, Simone E Pitts, Sonya M Edmonds, Sripal R Mada, PhD, Stacie A Woods, Stanley M Shepperson, State Agency, Stephanie A Cochran, Stephen D Brown, Stephen G Mclane, Stephen J Kilker, Steven C Madzo, Steven D Dittert, Steven Frisbee, Steven M Weinman, Steven P Donald, Susan M Jackson, Susan O Oladeji, Susan W Ting, Susanne M Richardson, MSc RAC ELS, Syed N Ali, Tammara A Stephens, Ted L Anderson, Teresa I Navas, Teresa Y Bills, Theresa Kirkham (NMI), Thomas B Smith, Thomas J Arista, Thomas O Morgan, Thomas R Stanley, Thomas S Savage, Timothy T Kapsala, Tina M Pawlowski, Tonia F Bernard, Tonya R Johnson, Tracy J Washington, Travis E Chapman, Truong Xuan Nguyen (Andy), Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vickie J Kanion, Vioela J Caze, Walden H Lee, Walter L Fava, Wanda B Coats, Wayne S Fortenberry, Wayne T Smith, Wendy R Blame, Whitney M White, Xiaokuang Lai, PhD, Yuesheng Ye, Yumi J Hiramine, Zada L Giles

George J Flynn's Documents

Publish Date Document Type Title
February, 2001 FDA 483 Response Qualitest Pharmaceuticals - Form 483R, 2001-02-06
May, 2000 FDA 483 Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals - Form 483, 2000-05-12
February, 2001 EIR Qualitest Pharmaceuticals - EIR, 2001-02-02
December, 2000 FDA 483 Chattem Chemicals, Inc. - Form 483, 2000-12-01
October, 2003 FDA 483 Delta Synthetic Co. Ltd. - Form 483, 2003-10-29
March, 2006 EIR CHATTEM, INC. - EIR, 2006-03-10
July, 2003 FDA 483 BioVectra Inc - Form 483, 2003-07-14
September, 2001 EIR Chattem Chemicals, Inc. - EIR, 2001-09-21
March, 2000 EIR Schering-Plough (Avondale) Company - EIR, 2000-03-08
June, 2000 FDA 483 SLOVAKOFARMA, 25 - Form 483, 2000-06-22
March, 2000 FDA 483 Response Schering-Plough (Avondale) Company - Form 483R, 2000-03-22
October, 2002 EIR Chifeng Arker Pharmaceutical Technology Co., Ltd. - EIR, 2002-10-09
October, 2000 FDA 483 Response Buchler GmbH - Form 483R, 2001-01-03
May, 2000 EIR Qualitest Pharmaceuticals - EIR, 2000-05-12
July, 2001 FDA 483 CHATTEM, INC. - Form 483, 2001-07-27
October, 2003 EIR Takeda Giken Service, Ltd. - EIR, 2003-12-11
June, 2000 EIR Spolana Sa - EIR, 2000-06-29
July, 2003 EIR Biotrial Bioanalytical Service - EIR, 2003-07-18
May, 2003 EIR Avanti Polar Lipids - EIR, 2003-05-01
July, 2001 EIR Robbins, Ivan M., MD - EIR, 2001-07-03
July, 2003 FDA 483 Response BioVectra Inc - Form 483R, 2003-08-05
July, 2002 FDA 483 Response Raylo Chemicals Inc. - Form 483R, 2002-07-23
April, 2004 FDA 483 Suzhou no. 4 Pharmaceutical Factory - Form 483, 2004-04-01
July, 2005 EIR Qualitest Pharmaceuticals - EIR, 2005-07-15
October, 2003 EIR YUNG SHIN PHARM. IND. CO., LTD. - EIR, 2003-11-26
October, 2003 FDA 483 Response Delta Synthetic Co. Ltd. - Form 483R, 2003-11-28
February, 2002 EIR Pharmaron Manufacturing Services (UK) Limited - EIR, 2002-02-20
November, 2002 FDA 483 Vi-Jon, LLC - Form 483, 2002-11-26
April, 2004 FDA 483 Response Suzhou no. 4 Pharmaceutical Factory - Form 483R, 2004-05-03
November, 2002 EIR Vi-Jon, LLC - EIR, 2002-11-26
October, 2003 FDA 483 Response YUNG SHIN PHARM. IND. CO., LTD. - Form 483R, 2004-01-26
July, 2002 EIR Raylo Chemicals Inc. - EIR, 2002-07-23
September, 2001 FDA 483 Chattem Chemicals, Inc. - Form 483, 2001-09-21
March, 2003 EIR Fujian Fukang Pharmaceutical Co., Ltd. - EIR, 2003-03-27
February, 2002 EIR AstraZeneca UK Ltd - EIR, 2002-02-15
March, 2002 EIR TriRx Huntsville Pharmaceutical Services, LLC - EIR, 2002-03-29
July, 2002 EIR Patheon Inc. - EIR, 2002-07-11
May, 2001 EIR Bayer Healthcare, LLC - EIR, 2001-05-25
January, 2004 FDA 483 PharMEDium Services, LLC. - Form 483, 2004-01-29
May, 2003 FDA 483 Avanti Polar Lipids - Form 483, 2003-05-01
May, 2003 FDA 483 Baxter Healthcare Corporation - Form 483, 2003-05-22
May, 2004 FDA 483 CHATTEM, INC. - Form 483, 2004-05-07
January, 2002 EIR Vi-Jon, LLC - EIR, 2002-01-11
June, 2003 FDA 483 Qualitest Pharmaceuticals - Form 483, 2003-06-13
April, 2000 EIR Michael H. Gold, MD - EIR, 2000-04-18
February, 2002 FDA 483 BASF PLC Cramlington Division - Form 483, 2002-02-20
October, 2003 EIR Delta Synthetic Co. Ltd. - EIR, 2003-11-18
May, 2006 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2006-05-19
October, 2000 FDA 483 Response VTT Chemical Technology - Form 483R, 2000-11-06
February, 2002 FDA 483 Response AstraZeneca UK Ltd - Form 483R, 2002-02-26
October, 2000 FDA 483 VTT Chemical Technology - Form 483, 2000-10-13
August, 2000 EIR Central Admixture Pharmacy Services Inc - EIR, 2000-08-09
June, 2000 FDA 483 Response Zentiva A.S. - Form 483R, 2000-07-11
April, 2004 EIR Suzhou no. 4 Pharmaceutical Factory - EIR, 2004-05-13
February, 2001 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2001-02-02
October, 2000 FDA 483 BASF AS avd Sandefjord - Form 483, 2000-10-18
March, 2003 FDA 483 Fujian Fukang Pharmaceutical Co. Ltd. - Form 483, 2003-03-27
February, 2006 FDA 483 USAntibiotics, LLC - Form 483, 2006-02-17
September, 2000 FDA 483 Bayer Healthcare LLC - Form 483, 2000-09-22
April, 2003 FDA 483 Aphena Pharma Solutions - Tennessee, LLC - Form 483, 2003-04-21
March, 2000 FDA 483 Schering-Plough (Avondale) Company - Form 483, 2000-03-08
July, 2004 FDA 483 Qualitest Pharmaceuticals - Form 483, 2004-07-02
February, 2001 EIR Siami, Ghodrat, M.D.,Ph.D., Clinical Investigator - EIR, 2001-02-15
January, 2004 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2004-01-23
October, 2003 FDA 483 Takeda Giken Service, Ltd. - Form 483, 2003-10-17
January, 2002 FDA 483 Response Vi-Jon, LLC - Form 483R, 2002-01-24
July, 2002 EIR Patheon Inc. - EIR, 2002-07-17
July, 2003 EIR Questcor Pharmaceuticals, Inc - EIR, 2003-07-14
October, 2000 EIR Buchler GmbH - EIR, 2000-10-25
February, 2000 EIR ALKERMES PHARMA IRELAND LIMITED - EIR, 2000-02-25
October, 2000 FDA 483 Buchler GmbH - Form 483, 2000-10-25
May, 2001 FDA 483 Response YUNG SHIN PHARM. IND. CO., LTD. - Form 483R, 2001-06-01
December, 2000 EIR Chattem Chemicals, Inc. - EIR, 2000-12-01
October, 2003 FDA 483 Response Takeda Giken Service, Ltd. - Form 483R, 2003-11-11
May, 2000 FDA 483 Response Qualitest Pharmaceuticals - Form 483R, 2000-06-09
July, 2001 FDA 483 Ivan M. Robbins, M.D. - Form 483, 2001-07-03
January, 2000 FDA 483 Vi-Jon, LLC - Form 483, 2000-01-07
February, 2002 FDA 483 Response Pharmaron Manufacturing Services (UK) Limited - Form 483R, 2002-02-20
October, 2002 EIR Chifeng Pharmaceutical Co. Ltd - EIR, 2002-10-09
March, 2006 FDA 483 CHATTEM, INC. - Form 483, 2006-03-10
April, 2006 FDA 483 Zhejiang Hisun Pharmaceutical Co., Ltd. - Form 483, 2006-04-20
January, 2002 FDA 483 Vi-Jon, LLC - Form 483, 2002-01-11
July, 2002 FDA 483 Patheon Inc. - Form 483, 2002-07-17
July, 2003 FDA 483 Ethypharm, Inc. - Form 483, 2003-07-24
March, 2002 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2002-03-29
March, 2004 FDA 483 Vi-Jon, LLC - Form 483, 2004-03-02
October, 2000 EIR VTT Chemical Technology - EIR, 2000-10-13
February, 2003 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2003-02-13
March, 2003 EIR Central Admixture Pharmacy Services Inc - EIR, 2003-03-05
May, 2001 EIR YUNG SHIN PHARM. IND. CO., LTD. - EIR, 2001-05-31
February, 2002 FDA 483 AstraZeneca UK Ltd - Form 483, 2002-02-15
May, 2002 FDA 483 Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals - Form 483, 2002-05-24
March, 2002 FDA 483 Response TriRx Huntsville Pharmaceutical Services, LLC - Form 483R, 2002-04-19
December, 2000 FDA 483 Response Chattem Chemicals, Inc. - Form 483R, 2000-12-29
May, 2005 FDA 483 Aphena Pharma Solutions - Tennessee, LLC - Form 483, 2005-05-11
June, 2000 EIR Zentiva A.S. - EIR, 2000-06-22
February, 2000 FDA 483 Response ALKERMES PHARMA IRELAND LIMITED - Form 483R, 2000-03-17
April, 2006 EIR Zhejiang Hisun Pharmaceutical Co., Ltd. - EIR, 2006-04-20
February, 2002 FDA 483 GE Healthcare Ireland Limited - Form 483, 2002-02-12
December, 2004 FDA 483 Charpier's Bakery - Form 483, 2004-12-02
June, 2001 EIR Eurofins Scientific Inc - EIR, 2001-06-05
May, 2006 FDA 483 Response TriRx Huntsville Pharmaceutical Services, LLC - Form 483R, 2006-06-15
February, 2003 FDA 483 Response TriRx Huntsville Pharmaceutical Services, LLC - Form 483R, 2003-02-13
July, 2003 FDA 483 Response Biotrial Bioanalytical Service - Form 483R, 2003-11-05
June, 2000 FDA 483 Spolana Sa - Form 483, 2000-06-29
July, 2001 EIR CHATTEM, INC. - EIR, 2001-07-27
July, 2003 EIR BioVectra Inc - EIR, 2003-07-14
March, 2003 EIR Tianjin Baiao Biotech Products Corp. - EIR, 2003-03-21
February, 2005 EIR Central Admixture Pharmacy Services Inc - EIR, 2005-02-24
January, 2000 EIR Vi-Jon, LLC - EIR, 2000-01-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more